Dr Reddys Laboratories RDY
NYSE RDY
$14.94 +0.03 (+0.20%)
As of: Nov 9, 2026 · 12:08 PM EST

Dr Reddys Laboratories (RDY) Gross Profit (2009 - 2026)

Updated

Dr Reddys Laboratories' Gross Profit came in at $472.93 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 14.3% from $551.91 million a year earlier but up 19.3% from the prior quarter.

Analysis

Dr Reddys Laboratories (RDY) Gross Profit (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Dr Reddys Laboratories reported Gross Profit of $1.76 billion, down 21.5% year-over-year; for FY2026 (ended Mar 31, 2026), it was $1.89 billion, down 15.3% from FY2025.

  • Gross Profit carries a five-year compound annual growth rate of 6.0% (FY2021 to FY2026).
  • Going back by fiscal year, Gross Profit was $2.23 billion in FY2025 (+13.6%), $1.96 billion in FY2024 (+15.8%), $1.7 billion in FY2023 (+13.0%) and $1.5 billion in FY2022 (+6.5%).
  • The five-year range for quarterly Gross Profit is $368.55 million (fiscal Q4 2026) to $580.96 million (fiscal Q3 2025).
  • Year-over-year, Gross Profit has declined for five consecutive quarters, with an average decline of 7.9% over the last eight quarters.
  • The fastest year-over-year change in Gross Profit over five years came in fiscal Q2 2023 (growth of 29.4%), and the weakest in fiscal Q4 2026 (a decline of 32.5%).
  • Business Quant data shows RDY's Gross Profit at $396.53 million (Q1 2027), $368.55 million (Q4 2026) and $525.61 million (Q3 2026) in the three fiscal quarters before Q2 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,246.80 Bn 1,220.42 Bn 20.46 Bn
2 Johnson & Johnson 674.35 Bn 594.21 Bn 17.30 Bn
3 AbbVie 517.12 Bn 485.13 Bn 13.12 Bn
4 Merck 364.12 Bn 327.06 Bn 13.19 Bn
5 Novartis Ag 315.40 Bn 288.64 Bn -
6 Astrazeneca 292.28 Bn 266.18 Bn 13.26 Bn
7 Amgen 250.93 Bn 202.58 Bn 7.58 Bn
8 Gilead Sciences 209.69 Bn 184.80 Bn 6.73 Bn
9 Pfizer 167.04 Bn 114.40 Bn 12.56 Bn
10 Dr Reddys Laboratories 12.44 Bn 11.78 Bn 472.93 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 472.93 Mn
Jun 30, 2026 396.53 Mn
Mar 31, 2026 368.55 Mn
Dec 31, 2025 525.61 Mn
Sep 30, 2025 551.91 Mn
Jun 30, 2025 568.19 Mn
Mar 31, 2025 545.79 Mn
Dec 31, 2024 580.96 Mn
Sep 30, 2024 570.33 Mn
Jun 30, 2024 555.56 Mn
Mar 31, 2024 499.52 Mn
Dec 31, 2023 506.85 Mn
Sep 30, 2023 488.33 Mn
Jun 30, 2023 486.00 Mn
Mar 31, 2023 476.00 Mn
Dec 31, 2022 439.00 Mn
Sep 30, 2022 488.00 Mn
Jun 30, 2022 450.00 Mn
Mar 31, 2022 382.26 Mn
Dec 31, 2021 379.00 Mn
API Access

Dr Reddys Laboratories Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=RDY&period=max&api_key=YOUR_API_KEY